NCT00724243 Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED) Status COMPLETED Phase N/A
NCT00705471 Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED) Status TERMINATED Phase N/A
NCT00705289 A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250) Status COMPLETED Phase N/A
NCT00688636 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery Status COMPLETED Phase PHASE4
NCT00687401 A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612) Status COMPLETED Phase PHASE3
NCT00687362 A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528) Status COMPLETED Phase PHASE2
NCT00686894 Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) Status TERMINATED Phase PHASE4
NCT00686686 Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00686595 A Study to Evaluate the Switch From Etanercept to Infliximab in Subjects With Moderate-to-Severe Psoriasis (Study P05133) Status COMPLETED Phase PHASE4
NCT00636142 Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity Status COMPLETED Phase PHASE4
NCT00629772 Safety and Efficacy of Infliximab in Palmoplantar Psoriasis Status COMPLETED Phase PHASE3
NCT00591201 Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies Status COMPLETED Phase PHASE2/PHASE3
NCT00589628 Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis Status COMPLETED Phase PHASE4
NCT00527072 PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept Status COMPLETED Phase PHASE3
NCT00523354 Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis Status COMPLETED Phase PHASE2
NCT00521924 Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED) Status TERMINATED Phase PHASE3